Ibritumomab tiuxetan therapeutic regimen: cutaneous reactions.(Safety ...
September 22, 2005
|
Veralipride: withdrawal following review of risk/benefit.(Regulatory A...
September 22, 2005
|
Influenza antiviral medicinal products for potential use during a pand...
September 22, 2005
|
Duloxetine hydrochloride and hepatic effects.(Safety and Efficacy Issu...
September 22, 2005
|
Withdrawal of Infanrix HepB[R].(Regulatory Action and News)(Brief arti...
September 22, 2005
|
Registration of fixed dose combinations.(Recent Publications, Informat...
September 22, 2005
|
Chronic airways disease guide.(Recent Publications, Information and Ev...
September 22, 2005
|
The Blue Guide on advertising.(Recent Publications, Information and Ev...
September 22, 2005
|
Sources and prices of HIV medicines and diagnostics.(Recent Publicatio...
September 22, 2005
|
Environmental risk assessment for human and veterinary medicinal produ...
September 22, 2005
|
EMEA proposes new, faster scientific advice procedure.(Regulatory Acti...
September 22, 2005
|
Nelarabine approved for leukaemia and lymphoma.(Regulatory Action and ...
September 22, 2005
|
Pemoline: liver injury risk and market withdrawal.(Regulatory Action a...
September 22, 2005
|
International biosafety guidelines for influenza vaccine production.(R...
September 22, 2005
|
Influenza virus composition for 2006 southern hemisphere winter.(Regul...
September 22, 2005
|
Safety update on paediatric use of oseltamivir.(Regulatory Action and ...
September 22, 2005
|
Paroxetine: first trimester exposure and congenital malformations.(Saf...
September 22, 2005
|
Atomoxetine and suicidal thinking in children and adolescents.(Safety ...
September 22, 2005
|
Liquid chemical polymer and serious adverse events.(Safety and Efficac...
September 22, 2005
|
Interactions with implantable medical devices.(Safety and Efficacy Iss...
September 22, 2005
|
Intrathecal baclofen: incidents with implantable drug pump system.(Saf...
September 22, 2005
|
Oseltamivir paediatric adverse events.(Safety and Efficacy Issues)
September 22, 2005
|
Trastuzumab: interim treatment recommendations.(Safety and Efficacy Is...
September 22, 2005
|
Trastuzumab and possible cardiotoxicity.(Safety and Efficacy Issues)
September 22, 2005
|
Meningococcal vaccine and Guillain Barre syndrome.(Safety and Efficacy...
September 22, 2005
|
New safety information on long-acting beta-2 agonists.(Safety and Effi...
September 22, 2005
|
Statins and memory loss.(Safety and Efficacy Issues)
September 22, 2005
|
WHO International Drug Monitoring Programme: 28th meeting.(Safety and ...
September 22, 2005
|
Safety challenges of preventing malaria during pregnancy.(Safety and E...
September 22, 2005
|
Avian influenza: impact on health programmes.(Drug Management)
September 22, 2005
|
Launch of new medicines website.
September 22, 2005
|
Priority medicines for Europe and the world.(Recent Publications, Info...
September 22, 2005
|
International Nonproprietary Names for Pharmaceutical Substances (INN)...
September 22, 2005
|
Monograph for oral powders.(International Pharmacopoeia)
September 22, 2005
|
Screening guidelines for women exposed to DES in utero.(Recent Publica...
September 22, 2005
|
Promoting drug use in the community.(Recent Publications, Information ...
September 22, 2005
|
Precautionary suspension of Hexavac[R]: lowered immunogenicity.(Regula...
September 22, 2005
|
Canada and the "Jean Chretien Pledge to Africa".(Access to Medicines)(...
September 22, 2005
|
Duloxetine hydrochloride and hepatic effects.(Safety and Efficacy Issu...
September 22, 2005
|
